Weatherall, Jim (AstraZeneca 202110 VP Data Science + Ai, RnD) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
Weaver, Aaron (Apeiron Investment 202110 Principal) |
Principal (venture capital) |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta |
Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) |
Chief Executive Officer (CEO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
Weber, Albert (Epigenomics 201801– promoted CFO joined 2010 before Pironet AG + EMI Group Germany) |
Chief Financial Officer (CFO) |
Epigenomics (Group) |
Germany |
Weber, Barbara (Tango Therapeutics 201804 CEO + Board Member of Revolution Medicines before Novartis) |
Chief Executive Officer (CEO) |
Tango Therapeutics Inc. |
United States (USA) |
Weber, Christoph (Teltow-Fläming (govt) 201005 Division Head Biotechnologiepark Luckenwalde) |
science park |
Teltow-Fläming (county govt) |
Germany |
Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Japan |
Weber, Dirk (Cellestia Biotech 201801 CMO) |
Chief Medical Officer (CMO) |
Cellestia Biotech AG |
Switzerland |
Weber, Frank (Polyphor 201901– CMDO before InterMune EU + Merck Serono + American Cyanamid/Lederle + Synthelabo + Merck) |
Chief Medical Officer (CMO) |
Spexis (Group) |
Switzerland |
Weber, Johannes F. (High-Tech Gründerfonds 202309 Senior Investment Manager formerly Bentekk) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Weber, Lutz (OntoChem 200509– before Priaton GmbH) |
Managing Director |
Holtzbrinck (Group) |
Germany |
Weber, Martin (Qiagen GmbH 200706 also VBU Board Member 200706) |
n. a. |
Qiagen (Group) |
Germany |
Weber, Matthias G. (Danaher 2012–2019 President of Leica Biosystems) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) |
Chief Financial Officer (CFO) |
Eurofins (Group) |
France |
Weber, Michael (MCG Motion Capture 201910 Managing Director) |
Managing Director |
MCG Motion Capture GmbH (Motion Capture Group) |
Germany |
Weber, Moritz (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Weber, Olaf (Bayer 201910 Head Radiology RnD) |
n. a. |
Bayer (Group) |
Germany |
Weber, Tim O. (Parter Capital 201411 Board Chairman) |
Board member, executive |
Parter Capital Group AG |
Switzerland |
Weber, Wolfgang (TU Munich 202010 Professor + Director of Dept of Nuclear Medicine) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
Weckesser, Volkmar (Centogene 202004 CIO) |
Chief Information Officer (CIO) / Chief Digital Officer |
Centogene (Group) |
Germany |
Weddrin, Willi (Hannover Capital 201104 Managing Director) |
Managing Director |
Hannover Capital Partners Management GmbH (HCP) |
Germany |
Wedel, Adolf (PhytoLab GmbH & Co KG 201208 Managing Director) |
Managing Director |
Martin Bauer Group (Group) |
Germany |
Wedershoven, Volker (Imevax GbmH 201410– Managing Director) |
Managing Director |
Imevax GmbH |
Germany |
Wedlake, Bill (NextPharma 200301– CEO before CFO since 7/00) |
Chief Executive Officer (CEO) |
NextPharma (Group) |
United Kingdom (GB) |
Wegeler, Nikola (Immatics 201801 Media Contact) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
Wegener, Bernd (Deutsche Biotech Innovativ AG before BRAHMS CEO) |
Chief Executive Officer (CEO) |
Deutsche Biotech Innovativ (Group) |
Germany |
Weglöhner, Wolfgang (InVivo Biotech Services 201105 Managing Director (CEO + CSO) + Co-Founder) |
Managing Director |
Bruker (Group) |
Germany |
Wehland, Jürgen (Helmholtz 201003 Scientific Director HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Wehmeier (formerly Klotzsche), Oliver (Evotec 201403 VP Business Develoment before CCS Cell Culture Service) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
Wehmeier, Lutz (Schott Nexterion 200412 General Manager) |
General Manager (management) |
Schott (Group) |
Germany |
Wehner, David (Venneos 2014– Managing Director + Co-Founder) |
Managing Director |
Venneos GmbH |
Germany |
Wehren, Achim (Tecan 200407 Marketing Manager Biopharma) |
n. a. |
Tecan (Group) |
Switzerland |
Wehselau, Stephan (Xantos 200309 promoted to CEO) |
Chief Executive Officer (CEO) |
Xantos Biomedicine AG |
Germany |
Weichert, Andreas G. (Dr. Weichert – Life Sciences Consulting 201109) |
Consultant (economic/technology) |
Dr. Weichert – Life Sciences Consulting, Andreas Weichert |
Germany |
Weichert, Tilman (CMS 201811 Partner bei CMS Hasche Sigle) |
Attorney / Lawyer |
CMS (Group) |
Germany |
Weichselgartner, Michael |
n. a. |
Eurofins (Group) |
Germany |
Weickert, Marie-Theresa (Trophic Communications 201906) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
Weidanz, Debra (AbeXXa Biologics 201712 CEO) |
Chief Executive Officer (CEO) |
AbeXXa Biologics Inc. |
United States (USA) |
Weidner, Gerhard |
n. a. |
Geneworx AG |
Germany |
Weig, Michael (Univ Göttingen 201011 PD Institute for Medical Microbiology) |
Researcher (university / research institute) |
University of Göttingen (Georg August University) |
Germany |
Weigel, Detlef |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Weigert, Barbara (Sachsen (govt) 202207 Saxony Trade + Invest Life Sciences Inward Investment) |
Trade Promotion Manager / Regional Business Development Manager |
Saxony (govt region) |
Germany |
Weikert, Gunnar (Inventages Venture Capital 201609 Founder) |
Company Founder |
Inventages Venture Capital Investments Inc. |
Switzerland |
Weil, Ingrid (Fidura Private Equity Fonds 201311 Managing Director of IWF Fondsconsult GmbH) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Germany |
Weiland, Barbara (Merck (DE) 201402– Head of Group Internal Auditing) |
Financial Manager (CFO, Financial Director, etc.) |
Merck (DE) (Group) |
Germany |
Weiler, Andreas (Lonza 201505 Head of Emerging Technology, Lonza Pharma&Biotech) |
n. a. |
Lonza (Group) |
Switzerland |
Weiler, Lutz (Equinet Bank 201410 CEO) |
Chief Executive Officer (CEO) |
Equinet (Group) |
Germany |
Weiler, Tobias (SPECTARIS 201109 Managing Director) |
Managing Director |
SPECTARIS – Deutscher Industrieverband für optische, medizinische und mechatronische Technologien e. V. |
Germany |
Weilermann, Wolfgang (NascaCell 200809 Chairman Supervisory Board) |
Board member, non-executive |
NascaCell (Group) |
Germany |
Weilguni, Peter C. (Cytoprotec 201301 Managing Director) |
Managing Director |
Zytoprotec GmbH |
Austria |
Weimann, Christoph (vierviertel 201504 Managing Partner) |
Managing Director |
vierviertel – Agentur für Kommunikationsdesign GmbH |
Germany |
Wein, Wolfgang (Merck KGaA 200511 Executive VP Oncology) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
Weinand, Dieter (Sanofi 201811– Head Primary Care Unit before Bayer + Otsuka + Pfzer + BMS) |
President/Director/Head Business Group/Unit/Division |
Sanofi (Group) [since May 2011] |
|
Weinberg, Serge (Sanofi 201906 Board Chairman) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
France |
Weinberger, Klaus (Bavarian Nordic 201202 VP R&D at Bavarian Nordic GmbH before Biocrates CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bavarian Nordic (Group) |
Germany |
Weiner, Olaf (directif GmbH 200503 Managing Director) |
Chief Executive Officer (CEO) |
November (Group) |
Germany |
Weinhagen, Marcus (Trinos 1997– Managing Director + co-founder Trinos Vakuum-Systeme GmbH) |
Managing Director |
Pfeiffer Vacuum (Group) |
Germany |
Weinschenk, Toni (Immatics 202309 Chief Innovation Officer) |
n. a. |
Immatics (Group) |
Netherlands |
Weinstein, Edward (Canopy Biosciences 201904 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
Weinstein, Jack (Relief Therapeutics 202010– CFO before Avalon Group + Catalyst Pharmaceuticals + Sterlington Group) |
Chief Financial Officer (CFO) |
Relief Therapeutics (Group) |
Switzerland |
Weintritt, Holger (Bayer 2022203 Head of Pharma Product Supply + Member of Executive Committee at Bayer Pharma) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983) |
Chief Executive Officer (CEO) |
Sosei (Group) |
United Kingdom (GB) |
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) |
Chief Executive Officer (CEO) |
Sitryx Therapeutics Ltd. |
United Kingdom (GB) |
Weis, Alexander L. (OncoVista 20106 CEO + AdnaGen 201011 CEO) |
Chief Executive Officer (CEO) |
OncoVista (Group) |
United States (USA) |
Weisener, Thomas (HNP Mikrosysteme GmbH 201104 Managing Director) |
Managing Director |
HNP Mirosysteme GmbH |
Germany |
Weiser, Weishui (Coral BioNet 2006c–201102 CEO Scil Technology GmbH retired 2/00) |
Chief Executive Officer (CEO) |
Coral BioNet (Group) |
Germany |
Weisman, Howard (Seventh Sense Biosystems 201408 CEO) |
Chief Executive Officer (CEO) |
Seventh Sense Biosystems Inc. (7SBio) |
United States (USA) |
Weiss, Andrew C. (Idorsia 201706– SVP + Head Investor Relations + Corporate Communications before Actelion) |
Public Relations Manager / Investor Relations Manager |
Idorsia (Group) |
Switzerland |
Weiss, Brian (Carebox Healthcare Solutions 202002 CEO) |
Chief Executive Officer (CEO) |
Carebox Healthcare Solutions Inc. |
United States (USA) |
Weiss, Christian (Creathor Ventures 201707 Partner) |
Partner (venture partner) |
Creathor Ventures (Group) |
Germany |
Weiss, Gunter (InfanDx 202108– COO before Epigenomics 200810 VP Product Development) |
Chief Operating Officer (COO) |
InfanDx (Group) |
Germany |
Weiss, Joachim (Thermo Fisher 201411 Technical Director Chromatography + MS division) |
Support Manager / Service Manager |
Thermo Fisher (Group) |
United States (USA) |
Weiss, Ludwig (SciXess GmbH 201105 Managing Director + CAST Tirol before HepaVec + MondoGen) |
n. a. |
SciXess GmbH Beratungs- und Beteiligungs mbH |
|
Weiss, Mario (GAIA 201702 CEO + Founder) |
Chief Executive Officer (CEO) |
GAIA AG |
Germany |
Weiss, Patrick A. (200406– Operon before Qiagen Operon) |
n. a. |
Eurofins (Group) |
United States (USA) |
Weisshuhn, Philip (Beroceutica GmbH 201606– Managing Director + Co-Founder) |
Managing Director |
Beroceutica GmbH |
Germany |
Weissman, Drew (Univ Pennsylvania 201811 Prof of Medicine) |
Researcher (university / research institute) |
University of Pennsylvania (UPenn) |
United States (USA) |
Weissmann, Charles (Evotec Biosystems 199906 Scientific Advisory Board) |
Advisory Board member |
Evotec (Group) |
Germany |
Weitemeyer, Nathalie (Bayern Kapital 201112 Senior Investment Manager) |
Investment Manager |
Bavaria (govt region) |
Germany |
Weitkemper, Norbert (Cognis 200810 Director BusiDevelop Nutrition) |
Business Development Manager / Strategy Manager |
Cognis (Group) |
Germany |
Weitnauer, Wolfgang (Weitnauer Partnerschaft mbB 202308 Attorney + Partner) |
Attorney / Lawyer |
Weitnauer Partnerschaft mbB Rechtsanwälte Steuerberater |
Germany |
Weitsch, Anne-Fabienne (Ncardia 201712 VP Corp Developm + Legal before Signature Diagnostics + Hybrigenics SA) |
Business Development Manager / Strategy Manager |
Kiniciti Bio (WCAS invesment platform) (Group) |
Belgium |
Weißer, Jürgen U. (RheinCell Therapeutics 201709– Managing Director) |
Managing Director |
Catalent (Group) |
Germany |
Welbers, Stefan (Evonik 201806 SVP + General Manager of CyPlus GmbH) |
General Manager (management) |
Evonik (Group) |
Germany |
Welch, Dan (InterMune 200512 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Wellauer, Thomas (Novartis 200702 Head Corporate Service) |
n. a. |
Novartis (Group) |
Switzerland |
Weller, Ulrich (Labor Boogen Köln 200909 Head Microbiology) |
Laboratory Manager (industry) |
Praxis für Laboratoriumsmedizin, Hämostaseologie Dr. med. Christiane Boogen (Labor Boogen Köln) |
Germany |
Wells, Tim (Medicines for Malaria 201102 CEO) |
Chief Executive Officer (CEO) |
UN (United Nations) |
|
Welp, Karin Irene (MorphoSys 201106 Managing Director of MorphoSys AbD GmbH) |
Managing Director |
Bio-Rad (Group) |
Germany |
Welsch, Klaus (BASF 200808 Head Crop Protection Business Europe) |
n. a. |
BASF (Group) |
Germany |
Welschof, Martin (BioInvent 2019 CEO before Affitech 2002– COO promoted CEO 6/03 before Axaron) |
Chief Executive Officer (CEO) |
BioInvent International AB (Nasdaq Stockholm: BINV) |
Sweden |
Welte, Stefan (Inovedis 202106 Managing Director + Co-Founder) |
Managing Director |
Inovedis GmbH |
Germany |
Welte, Tobias (Medizinische Hochschule Hannover 200606 Prof) |
n. a. |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Welten, Harry (Cytos Biotechnology 201203 CFO) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Switzerland |
Welter, Oliver (Nia Health 202305 Managing Director) |
Managing Director |
Nia Health GmbH |
Germany |
Welters, Peter (Phytowelt 201106 Managing Director) |
Managing Director |
Phytowelt GreenTechnologies GmbH |
Germany |
Weltmann, Klaus-Dieter (Leibniz Gemeinschaft 201412 Director of INP Greifswald) |
President/Director/Head of Research Organisation/Unit |
Leibniz-Gemeinschaft |
Germany |
Wencker, Dominique (Dutscher 202108 CEO) |
Chief Executive Officer (CEO) |
Dutscher (DD) (Group) |
France |
Wende, Jan (Mediq Innovation Partners GmbH 201707 Managing Director) |
Managing Director |
Mediq Innovation Experts (Group) |
Germany |
Wendeln, Bernd |
n. a. |
|
|